The rapid availability of special k for acquisition online is generating mounting concern among regulators and healthcare professionals across several countries : the US , Canada, the United Kingdom , and Down Under . Unlicensed platforms are emerging, often enabling the provision of this controlled substance to individuals without proper evaluatio